DNAGinkgo Bioworks Holdings, Inc.

NYSE ginkgobioworks.com


$ 7.24 $ 0.30 (4.25 %)    

Wednesday, 18-Sep-2024 11:48:50 EDT
QQQ $ 471.67 $ -2.89 (-0.61 %)
DIA $ 416.70 $ -0.20 (-0.05 %)
SPY $ 561.75 $ -2.11 (-0.37 %)
TLT $ 100.20 $ -0.12 (-0.12 %)
GLD $ 237.38 $ -0.81 (-0.34 %)
$ 6.81
$ 6.94
$ 6.80 x 500
$ 7.23 x 100
$ 6.82 - $ 7.26
$ 5.26 - $ 82.80
3,314,143
na
378.47M
$ 2.58
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 02-29-2024 12-31-2023 10-K
4 11-08-2023 09-30-2023 10-Q
5 08-09-2023 06-30-2023 10-Q
6 05-10-2023 03-31-2023 10-Q
7 03-13-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 03-28-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-16-2021 06-30-2021 10-Q
14 05-24-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 whats-going-on-with-ginkgo-bioworks-stock-this-week

Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares continue to trade higher after rising nearly 10% on Tuesday. Here's a look a...

 google-cloud-expands-its-partnership-with-ginkgo-bioworks-for-two-new-ai-tools-faster-drug-development

Ginkgo Bioworks introduces a protein large language model and API, developed with Google Cloud, to streamline drug discovery by...

 ginkgo-bioworks-stock-is-rallying-tuesday-heres-why

Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares are surging Tuesday after the company announced the launch of its new protein la...

 ginkgo-bioworks-awarded-118m-us-government-hhs-contract

https://sam.gov/opp/7b8e625f7406478681bcd5af07ca7f2b/view

 ginkgo-regains-nyse-compliance
Ginkgo Regains NYSE Compliance
09/04/2024 20:33:52

 btig-maintains-sell-on-ginkgo-bioworks-holdings-adjusts-price-target-to-7-1-40-reverse-stock-split

BTIG analyst Mark Massaro maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell, adjusts target to $7 from $0.2 (1-40 Rever...

 ginkgo-bioworks-holdings-q2-2024-gaap-eps-011-misses-007-estimate-sales-5621m-beat-4314m-estimate

Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate ...

 goldman-sachs-maintains-sell-on-ginkgo-bioworks-holdings-lowers-price-target-to-03

Goldman Sachs analyst Matthew Sykes maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell and lowers the price target fr...

 cathie-woods-ark-invest-acquires-73m-worth-of-shares-in-this-promising-netflix-competitor-sells-off-coinbase-stock-amid-bitcoin-slump

On Wednesday, Cathie Wood-led Ark Invest made significant trades in Roku Inc (NASDAQ:ROKU) and Coinbase Global Inc (NASDAQ:COIN...

 btig-maintains-sell-on-ginkgo-bioworks-holdings-lowers-price-target-to-02

BTIG analyst Mark Massaro maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell and lowers the price target from $0.5 to...

 ginkgo-bioworks-says-on-june-17-it-began-implementing-previously-announced-restructuring-with-headcount-reductions-which-it-expects-to-result-in-total-reduction-of-at-least-35-of-workforce-when-all-impacted-employees-have-departed---filing

As previously announced, on May 9, 2024, in connection with the Company’s multi-year plan to reduce operational expenditures, m...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION